Apo-Nitrofurantoin en es it fr

Apo-Nitrofurantoin Brand names, Apo-Nitrofurantoin Analogs

Apo-Nitrofurantoin Brand Names Mixture

  • No information avaliable

Apo-Nitrofurantoin Chemical_Formula


Apo-Nitrofurantoin RX_link


Apo-Nitrofurantoin fda sheet

Apo-Nitrofurantoin msds (material safety sheet)

Apo-Nitrofurantoin MSDS

Apo-Nitrofurantoin Synthesis Reference

No information avaliable

Apo-Nitrofurantoin Molecular Weight

238.157 g/mol

Apo-Nitrofurantoin Melting Point

263 oC

Apo-Nitrofurantoin H2O Solubility

79.5 mg/L

Apo-Nitrofurantoin State


Apo-Nitrofurantoin LogP


Apo-Nitrofurantoin Dosage Forms


Apo-Nitrofurantoin Indication

For the treatment of infection of the urinary tract

Apo-Nitrofurantoin Pharmacology

Nitrofurantoin, a nitrofuran antibacterial agent, is available in microcrystalline and macrocrystalline form to treat urinary tract infections caused by many gram-negative and some gram-positive bacteria.

Apo-Nitrofurantoin Absorption

No information avaliable

Apo-Nitrofurantoin side effects and Toxicity

No information avaliable

Apo-Nitrofurantoin Patient Information

Patients should be advised to take Macrobid with food (ideally breakfast and dinner) to further enhance tolerance and improve drug absorption. Patients should be instructed to complete the full course of therapy; however, they should be advised to contact their physician if any unusual symptoms occur during therapy.

Patients should be advised not to use antacid preparations containing magnesium trisilicate while taking Macrobid.

Patients should be counseled that antibacterial drugs including Macrobid should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Macrobid is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Macrobid or other antibacterial drugs in the future.

Apo-Nitrofurantoin Organisms Affected

Gram negative and some gram positive bacteria